Abstract
Introduction A controversial topic in interventional cardiology is the method of revascularization for patients with diabetes. Subanalyses from several studies have suggested that longterm mortality risk varies between percutaneous coronary intervention (PCI) and coronary artery bypass graft surgery (CABG) for diabetic patients, but there remain inconsistencies in the literature. Additionally, the clinical course of diabetic patients undergoing PCI is complicated by more frequent restenosis compared with nondiabetic patients, particularly in small-diameter vessels and a higher rate of acute complications. Recent therapeutic advances in PCI have demonstrated promise in improving outcomes for diabetic patients, and their application to this high-risk patient population specifically has become the focus of intense investigation. This commentary reviews the controversy regarding the type of revascularization for patients with diabetes, and discusses the impact of new technology advances in revascularization for these high-risk patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
